CytomX Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $457.1M
Liabilities Breakdown FY2018
Total Liabilities: $326.2M
Asset Breakdown
Total Assets: $457.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $247.6M | 54.2% |
| Accounts Receivable | $97.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $6.9M | 1.5% |
| Goodwill | $949.0K | 0.2% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $201.6M | 44.1% |
Liabilities Breakdown
Total Liabilities: $326.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.1M | 1.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $321.1M | 98.4% |